Bone mineral status in juvenile rheumatoid arthritis
- PMID: 10782854
Bone mineral status in juvenile rheumatoid arthritis
Abstract
Osteoporosis can be thought of as a disease of childhood with manifestations in the adult years. One strategy in prevention of osteoporosis is to maximize peak bone mass with interventions focused during the childhood and adolescent years, taking advantage of this unique window of opportunity to maximize bone mass accrual, maximize peak bone mass, and theoretically decrease fracture risk for life. Factors important in the development of peak bone mass in children are reviewed. Studies examining bone metabolism and bone density in children with juvenile rheumatoid arthritis (JRA) are summarized. There is much work to be done before the best treatments for the osteoporosis of JRA are defined. Optimizing calcium intake and physical activity, along with corticosteroid avoidance and control of disease activity, is sound management for children with JRA.
Similar articles
-
Estimation of bone mineral density in children with juvenile rheumatoid arthritis.J Rheumatol. 1991 Aug;18(8):1235-9. J Rheumatol. 1991. PMID: 1941831
-
A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.Arthritis Rheum. 2006 Jul;54(7):2235-42. doi: 10.1002/art.21956. Arthritis Rheum. 2006. PMID: 16802360 Clinical Trial.
-
Musculoskeletal abnormalities of the tibia in juvenile rheumatoid arthritis.Arthritis Rheum. 2007 Mar;56(3):984-94. doi: 10.1002/art.22420. Arthritis Rheum. 2007. PMID: 17328076
-
Osteoporosis in childhood rheumatic diseases: prevention and therapy.Best Pract Res Clin Rheumatol. 2002 Jul;16(3):397-409. Best Pract Res Clin Rheumatol. 2002. PMID: 12387807 Review.
-
Prenatal and childhood influences on osteoporosis.Best Pract Res Clin Endocrinol Metab. 2002 Jun;16(2):349-67. doi: 10.1053/beem.2002.0199. Best Pract Res Clin Endocrinol Metab. 2002. PMID: 12064897 Review.
Cited by
-
Osteoporosis.Curr Rheumatol Rep. 2001 Oct;3(5):365-70. doi: 10.1007/s11926-996-0005-7. Curr Rheumatol Rep. 2001. PMID: 11564366 Review.
-
Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study.Pediatr Rheumatol Online J. 2010 Dec 6;8:30. doi: 10.1186/1546-0096-8-30. Pediatr Rheumatol Online J. 2010. PMID: 21134287 Free PMC article.
-
Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.Clin Rheumatol. 2008 Mar;27(3):289-94. doi: 10.1007/s10067-007-0701-3. Epub 2007 Aug 17. Clin Rheumatol. 2008. PMID: 17703334
-
Safety and feasibility of a home-based six week resistance training program in juvenile idiopathic arthritis.Pediatr Rheumatol Online J. 2013 Dec 20;11(1):46. doi: 10.1186/1546-0096-11-46. Pediatr Rheumatol Online J. 2013. PMID: 24359015 Free PMC article.
-
Secondary osteoporosis in patients with juvenile idiopathic arthritis.J Osteoporos. 2011 Feb 20;2011:569417. doi: 10.4061/2011/569417. J Osteoporos. 2011. PMID: 21403891 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical